A carregar...
Neoadjuvant endocrine therapy in breast cancer patients
HIGHLIGHTS: The overall response rate to neoadjuvant endocrine therapy (NET) was 54.55%. The eight patients proposed to tumour's downstage, after 9.71 months of NET, preserved their breast. In the group which achieved response, 10.28 months was the mean time to accomplish it. Even patients who...
Na minha lista:
| Publicado no: | Porto Biomed J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Faculty of Medicine of the University of Porto
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806912/ https://ncbi.nlm.nih.gov/pubmed/32258615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbj.2017.03.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|